Portage Biotech Inc (NASDAQ:PRTG)
| 9.84 Delayed Data As of May 27 |  +0.50 / +5.35%Today’s Change | 4.62 Today|||52-Week Range 44.98 | -8.29% Year-to-Date |
Latest PRTG News | Press Releases
No recent news for Portage Biotech Inc.
Today’s Trading
| Previous close | 9.34 |
| Today’s open | 9.38 |
| Day’s range | 9.03 - 10.44 |
| Volume | 41,670 |
| Average volume (3 months) | 31,514 |
| Market cap | -- |
Data as of 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -177.08% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PIRSPieris Pharmaceutica... | +0.04 | +2.37% |
| VBLTVascular Biogenics L... | +0.19 | +10.73% |
| CUECue Biopharma Inc | +0.28 | +7.82% |
| URGNUrogen Pharma Ltd | +0.27 | +5.22% |
Data as of 4:00pm ET, 05/27/2022
Financials
| Next reporting date | June 1, 2022 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$15.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
Chart unavailable
